1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:

Follow-up, biopsy findings, and definitive diagnosis of 16 pseudotumoral lesions

Case No.Follow-up (Months/Evolution of Lesion)Histologic ExaminationFinal Diagnosis
277 m/Focal atrophyNoAcute arterial infarct
1326 m/Lesion regression. Detection of new lesions on follow-upYes, brain tissue without abnormalitiesMultiple sclerosis
1714 m/Lesion regressionNoAcute disseminated encephalomyelitis
2830 m/Lesion regressionYes, brain tissue without abnormalitiesMultiple sclerosis
332 m/Lesion regressionNoUnspecific
3475 m/Lesion regression. Detection of new lesions on follow-upYes, inflammatory, gliosisMultiple sclerosis
4235 m/Focal atrophyYes, inflammatory, gliosisUnspecific
5230 m/Lesion regression. Resolution of contrast enhancementYes, inflammatory, gliosisUnspecific
608 m/Lesion regression. Resolution of contrast enhancementNoMultiple sclerosis
6227 m/Lesion regressionYes, inflammatoryUnspecific
6420 m/Lesion regression. Resolution of contrast enhancementNoUnspecific
688 m/Lesion resolutionYes, inflammatoryUnspecific
726 m/Lesion regression. Focal atrophyNoAcute arterial infarct
7811 m/Lesion regressionNoAcute arterial infarct
804 m/Lesion regressionNoVenous infarct
828 m/Lesion regressionNoMultiple sclerosis